Study Description: The purpose of this study is to understand the role of the enzyme Indoleamine 2,3-dioxygenase (IDO) in renal transplant rejection. IDO is thought to play a role in preventing the immune systems's attack on transplanted organs, which is called rejection. This study is designed to check levels of IDO activity in transplanted kidneys and correlate these levels to other information such as whether there is active renal rejection and time since transplantation.
Principal Investigator: Carlos Zayas
Eligibility Criteria: subect 18 years of age or older has received a renal transplant is scheduled to undergo a renal transplant biopsy as part of your medical evaluation
Compensation: No, subjects will not be compensated.
If you don't see specific studies that interest you, please submit your contact information for future studies.